PROTEIN METRICS INC — Department of Health and Human Services STTR Phase I: 100

PROTEIN METRICS INC — STTR Phase I award from Department of Health and Human Services.

Amount
$224,870
Agency
Department of Health and Human Services · National Institutes of Health
Program / Phase
STTR · Phase I
Topic
100
Solicitation
PA16-303
NAICS
Place of performance
CA
Period
2017-09-01 → 2019-02-28

Description

Summary The use of mass spectrometry MS for quantitative protein characterization has increased dramatically identifying and quantifying thousands of proteins is no longer a heroic task nor is characterizing therapeutic proteins in detail Due to widely available software quantitative mass spectrometry has become routine and widely used for addressing questions in basic biology translational medicine and drug development MS Methods are now poised to have similar impact on the study of protein protein interaction and higher order structure HOS determination In particular crosslinking mass spectrometry which obtains distance and accessibility constraints from two ended chemical modifications is emerging as a powerful tool to map protein protein interaction interfaces Recent years have seen large improvements in crosslink mass spectrometry Yet despite these advances crosslink analysis is not yet a technique that has found widespread use due to a range of problems such as the low abundance of crosslinked peptides unavailability of proprietary reagents the need for different search algorithms adopted to specific cross linkers and the difficulty of reliably characterizing crosslinked peptide spectra To alleviate these problems and democratize the use of crosslinking we propose to develop standardized and effective methods for crosslinking in conjunction with sensitive and accurate search algorithms incorporated into our well established Byonic search engine Our algorithms will support almost all commercially available crosslinking chemistries and most major peptide fragmentation methods ETD CAD HCD EthcD as well as cleavable and non cleavable crosslinkers The near universal applicability and ease of use of the software will promote rapid adoption of crosslinking mass spectrometry in academic research and biopharmaceutical development Narrative We propose to develop methods and commercial software products for easy determination of the structure and interactions of biologically important proteins The proposed project has the potential for great impact on human health in areas such as medical research drug and vaccine development and therapeutic protein characterization